Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Arch Toxicol. 2016 Oct 25;91(5):2209–2221. doi: 10.1007/s00204-016-1880-y

Figure 3.

Figure 3

Expression of A) ATF3, B) IDO1, and C) CDX2 in AhR- and TLR-activated MoDCs. Cells were treated with 10 nM TCDD, 100 nM FICZ, 50 μM I3C, or 50 μM kyn in absence or presence of LPS (50 ng/ml), CL075 (5 μg/ml), or poly(I:C) (5 μg/ml) for 24h. Results from real-time PCR are presented as mean ± SEM and the y-axis represents mRNA expression level as fold increase above control. a significantly higher than non-activated DC control, p < 0.05; b significantly higher than TLR- and AhR-activated MoDCs, p < 0.05